Zobrazeno 1 - 10
of 41
pro vyhledávání: '"Timothy D Clay"'
Autor:
Christy Ralph, Sumati Gupta, Matthew Zibelman, Brendan D Curti, Kevin J Harrington, Steven J O'Day, Andrew G Hill, David C Campbell, Gavin M Wright, David E Gerber, Jonathan E Rosenberg, Jaime R Merchan, Charles M Rudin, Hardev S Pandha, Wallace L Akerley, Daphne Day, Timothy D Clay, Ross R Jennens, Yixin Ren, Emmett V Schmidt, Lisa Guttman
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss 1 (2023)
Background Oncolytic virus V937 showed activity and safety with intratumoral administration. This phase 1 study evaluated intravenous V937±pembrolizumab in patients with advanced solid tumors.Methods Patients had advanced non-small cell lung cancer
Externí odkaz:
https://doaj.org/article/07dff5f507bc4d64bce5f819f24c264d
Publikováno v:
The Journal of international medical research. 50(12)
Since the invasion of Ukraine in February 2022, clinical trial conduct has become extremely challenging due to damage to the healthcare infrastructure and patient displacement. This current study aimed to estimate the number of cancer clinical trials
Autor:
Jin-Soo Kim, Dennis R. Taaffe, Daniel A. Galvão, Timothy D. Clay, Andrew D. Redfern, Nicolas H. Hart, Elin S. Gray, Charles J. Ryan, Stacey A. Kenfield, Fred Saad, Robert U. Newton
PURPOSE: Although skeletal muscle releases cytokines called myokines during exercise, the kinetics of the acute myokine response to exercise (exercise-induced circulatory myokine level alteration) is unknown in patients with advanced prostate cancer.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c708784c7c5d6197124f09f96af47b8
https://hdl.handle.net/10453/164432
https://hdl.handle.net/10453/164432
Publikováno v:
Internal Medicine Journal. 51:1068-1073
BACKGROUND: Obtaining informed consent is an important responsibility of all doctors and is a major component of their day-to-day practice. However, little is known regarding practising doctors' understanding of consent in relation to medical law. AI
Autor:
Marliese Alexander, Joe Wei, Sagun Parakh, Thomas John, Steven Kao, Adnan Nagrial, Samantha Bowyer, Lydia Warburton, Melissa Moore, Brett G.M. Hughes, Timothy D. Clay, Nick Pavlakis, Benjamin J. Solomon, Malinda Itchins
Publikováno v:
JTO Clin Res Rep
INTRODUCTION: Over the past decade, ALK tyrosine kinase inhibitors have delivered unprecedented survival for individuals with ALK-positive (ALK+) lung cancers. Real-world data enhance the understanding of optimal drug sequencing and expectations for
Autor:
Christopher R, McEvoy, Damien, Kee, Owen W J, Prall, Timothy D, Clay, Clare, Scott, Anastasia, Backhouse, Stephen B, Fox, Andrew P, Fellowes, Huiling, Xu
Publikováno v:
JCO precision oncology. 3
Autor:
Charles M Rudin, Hardev S Pandha, Matthew Zibelman, Wallace L Akerley, Kevin J Harrington, Daphne Day, Andrew G Hill, Steven J O'Day, Timothy D Clay, Gavin M Wright, Ross R Jennens, David E Gerber, Jonathan E Rosenberg, Christy Ralph, David C Campbell, Brendan D Curti, Jaime R Merchan, Yixin Ren, Emmett V Schmidt, Lisa Guttman, Sumati Gupta
Publikováno v:
Journal for ImmunoTherapy of Cancer. 11:e005007
BackgroundOncolytic virus V937 showed activity and safety with intratumoral administration. This phase 1 study evaluated intravenous V937±pembrolizumab in patients with advanced solid tumors.MethodsPatients had advanced non-small cell lung cancer (N
Publikováno v:
JCO Oncology Practice
The novel 2019 coronavirus disease (COVID-19) pandemic is a global public health emergency. To date, physical distancing and good personal hygiene have been the only effective measures to limit spread. The pandemic has altered routine cancer care, in
Autor:
Yang Jian Ong, Nisha Sikotra, Janelle Prunster, Nicola Bailey, Jane Hadfield, Rosemary Smith, Rohen Skiba, Astrid Arellano, Eli Gabbay, Timothy D Clay
Publikováno v:
Clinical Audit.
Yang Jian Ong,1â 3 Nisha Sikotra,1,4 Janelle Prunster,1,2 Nicola Bailey,2 Jane Hadfield,2 Rosemary Smith,2 Rohen Skiba,2 Astrid Arellano,5 Eli Gabbay,1â 3,6 Timothy D Clay1,7,8 1Bendat Respiratory Research and Development Group, St John of
Publikováno v:
Journal of Medical Case Reports, Vol 15, Iss 1, Pp 1-9 (2021)
Journal of Medical Case Reports
Journal of Medical Case Reports
Background Immunotherapy has become an efficacious option in the management of solid organ malignancies. Immune-related adverse events including pneumonitis are well described and may be particularly of concern in patients receiving immunotherapy for